What do women want? If you ask the pharmaceutical industry, some will say women should have their own version of Viagra. And the drug companies really want to deliver. The most recent attempt to develop a magic pill for women, called Flibanserin and pioneered by the German pharmaceutical firm Boehringer Ingelheim, has rekindled a debate about whether a woman’s lack of sexual desire can be treated or enhanced by a drug.
Need to Know correspondent Rick Karr follows the pill’s progress, from the campaign to create a market for it to its appearance before an advisory committee of the U.S. Food and Drug Administration.
For further insight into the “female Viagra” debate and how it has played out in the media, check out Rick Karr’s podcasts on the topic: “Looking for the ‘little pink pill‘” and “Big media, big pharma, and ‘female Viagra.‘”